Nomogram integrating prognostic immune-inflammatory-nutritional score with clinicopathological parameters for predicting post-transplantation outcomes in hepatocellular carcinoma

Figure 7 Decision curve analysis of the prognostic immune-inflammatory-nutritional score based on prediction models for overall survival and disease-free survival. A: Comparison of decision curve analysis (DCA) curve of prognostic immune-inflammatory-nutritional (PIIN)-based prediction model, Milan criteria and University of California, San Francisco (UCSF) criteria for 1-year overall survival (OS) in the training set; B: Comparison of DCA curve of PIIN-based prediction model, Milan criteria and University of UCSF criteria for 3-year OS in the training set; C: Comparison of DCA curve of PIIN-based prediction model, Milan criteria and UCSF criteria for 5-year OS in the training set; D: Comparison of DCA curve of PIIN-based prediction model, Milan criteria and Risk Estimation of Tumor Recurrence After Transplant (RETREAT) score for 1-year disease-free survival (DFS) in the training set; E: Comparison of DCA curve of PIIN-based prediction model, Milan criteria and RETREAT score for 3-year DFS in the training set; F: Comparison of DCA curve of PIIN-based prediction model, Milan criteria and RETREAT score for 5-year DFS in the training set; G: Comparison of DCA curve of PIIN-based prediction model, Milan criteria and UCSF criteria for 1-year OS in the validation set; H: Comparison of DCA curve of PIIN-based prediction model, Milan criteria and University of UCSF criteria for 3-year OS in the validation set; I: Comparison of DCA curve of PIIN-based prediction model, Milan criteria and UCSF criteria for 5-year OS in the validation set; J: Comparison of DCA curve of PIIN-based prediction model, Milan criteria and RETREAT score for 1-year DFS in the validation set; K: Comparison of DCA curve of PIIN-based prediction model, Milan criteria and RETREAT score for 3-year DFS in the validation set; L: Comparison of DCA curve of PIIN-based prediction model, Milan criteria and RETREAT score for 5-year DFS in the validation set. UCSF: University of California, San Francisco; RETREAT: Risk Estimation of Tumor Recurrence After Transplant.